Research programme: COU-1 monoclonal antibodies - Affitech/NatImmune
Alternative Names: CaOU-1; COU 1; Human monoclonal antibody COU-1Latest Information Update: 07 Feb 2011
At a glance
- Originator Affitech AS; NatImmune
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Neoplasm protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Adenocarcinoma; Cancer; Colorectal cancer
Most Recent Events
- 25 Feb 2005 Antibodies from this programme are available for licensing worldwide (http://www.affitech.com)
- 31 Jul 2002 Preclinical trials in Cancer in Denmark (unspecified route)